Yeah, sadly a lot of Australians miss out on some great Australian bio-technology. I had two successive stem cell procedures in a decade in Australia that saved me from an awful prognosis and a terrible invasive poorly efficacious surgery, the first still only available via the SAS and the second no longer available at all. This stuff needs to be out there helping people with poor outlooks by traditional SOC.
Recruitment had been mind numbingly slow prior for Sculptor.
CYP Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)